miR-150-5p inhibits nasopharyngeal cancer genesis by suppressing PYCR1.

Li, Zhiqun; Zhou, Xiaoliu; Huang, Jiajun; Xu, Zhencai; Xing, Chengliang; Yang, Junwei; Zhou, Xuejun.

Afiliação

Li Z; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Zhou X; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Huang J; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Xu Z; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Xing C; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Yang J; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China.
Zhou X; Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou, 570102, Hainan, China. Electronic address: xuejunzhou65@163.com.

Am J Med Sci ; 2022 Jun 16.

Article em En | MEDLINE | ID: mdl-35718122